An important consideration for dual and tri-agonist peptides, is to monitor and clarify the clinical consequences on the cardiovascular system, especially the heart rate increase (147, 148)
Some patients taking GLP-1 medications report becoming pregnant after years of infertility
But another symptom many users report is fatigue
[] Recently, a new emerging interest in GLP-1 as therapeutic options for DM from their glucose-dependent mechanism of action, which enhances insulin secretion, reduces glucagon release, delays gastric emptying, and promotes satiety, ultimately helping control blood glucose without severe hypoglycemia
Gallbladder Problems: Including gallstones
[1] This central nervous system effect can amplify feelings of queasiness, especially during dose escalation phases